EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Activation of Anergic B Cells During Development of Autoimmunity

Mohammad Mansoor, Brandon K Hilliard, Mia J Smith iD

Immunological Reviews · 2026-09 · 342 (1)

DOI: 10.1111/imr.70175 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 06.09.2026. Verfasst von Mohammad Mansoor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Autoimmunity, Lymphocyte Activation, Clonal Anergy, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In healthy individuals, autoreactive B cells are normally silenced via central and peripheral tolerance mechanisms. In the periphery, when autoreactive B cells recognize self‐antigen via their B cell receptor (BCR) (signal 1) but do not receive T cell help (signal 2), they undergo the tolerance mechanism called anergy. Human anergic B cells are termed B ND (Naïve IgD+ B cells). Previous studies have shown that B ND cells are decreased in the peripheral blood of individuals with autoimmunity, suggesting they may have become activated and contributed to the development of disease. In line with this, recently it has been found that a portion of the remaining anergic B cells present in the blood of autoimmune individuals exhibit an activated phenotype. In this review, we will summarize what is known and unknown about these cells, including their relation to other recognized autoreactive B cell subsets, how they become activated in the first place, and what their pathogenic functions are. Understanding how B ND cells break tolerance and contribute to disease will advance the development of new therapeutic approaches and highlight novel cell populations amenable to depletion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityLymphocyte ActivationClonal AnergyB-LymphocytesB-Lymphocyte SubsetsAutoimmune DiseasesHumansAnimalsReceptors, Antigen, B-CellAutoantigensImmunoglobulin D

Substanzen

Receptors, Antigen, B-CellAutoantigensImmunoglobulin D

Autor:innen und Institutionen

  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Graduate Program in Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Mia J Smith

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Mansoor, M., Hilliard, B. K., & Smith, M. J. (2026). Activation of Anergic B Cells During Development of Autoimmunity. Immunological Reviews, 342(1). https://doi.org/10.1111/imr.70175

Vancouver

Mansoor M, Hilliard BK, Smith MJ. Activation of Anergic B Cells During Development of Autoimmunity. Immunological Reviews. 2026;342(1). doi:10.1111/imr.70175

BibTeX
@article{Mansoor2026,
  author = {Mansoor, Mohammad and Hilliard, Brandon K and Smith, Mia J},
  title = {Activation of Anergic B Cells During Development of Autoimmunity},
  journal = {Immunological Reviews},
  year = {2026},
  volume = {342},
  number = {1},
  doi = {10.1111/imr.70175}
}
Kostenlos starten →